HAYWARD, Calif., June 3, 2014 /PRNewswire/ -- Questcor
Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced its
sponsorship of the Lupus Foundation of America's (LFA) eight
national office Walk to End Lupus Now™ events and its
support of a variety of Lupus Awareness Month activities.
Questcor supported numerous lupus awareness, education and
advocacy activities throughout the country during Lupus Awareness
Month, which takes place each May. As a part of this effort,
Questcor employees proudly wore purple on May 16 to show their support for people with
lupus and raise awareness of the disease during the LFA's national
"Put On Purple" (POP) Day. The company is also sponsoring the
LFA's roster of national Walk to End Lupus Now events, part
of the world's largest lupus walk program being held throughout the
year.
"Questcor is excited to serve as a corporate sponsor of the
Lupus Foundation of America's Walk to End Lupus Now and was
a proud supporter of their national Lupus Awareness Month
programs," said Steve Cartt,
Questcor's Chief Operating Officer. "We are pleased to
support their research, education, and advocacy efforts focused on
improving the quality of life for all people affected by lupus. As
a company, we are also committed to serving the needs of lupus
patients, their families and the healthcare providers who care for
them."
Lupus is a chronic, autoimmune disease that can damage any part
of the body (skin, joints, and/or organs inside the body).
A lupus patient's immune system cannot properly tell
the difference between invading organisms and the body's healthy
tissues, and in turn creates antibodies that attack and destroy
healthy tissue. These antibodies cause inflammation, pain, and
damage in various parts of the body.
According to the LFA, lupus may affect as many as 1.5 million
Americans. Lupus strikes mostly women of childbearing
age (15-44), with African American women being two to three times
more likely to develop lupus than Caucasian women. Men,
children and teenagers may also develop lupus.
"We are very pleased to welcome Questcor as a corporate sponsor
for our Walk to End Lupus Now program and thank them for
supporting our efforts to raise awareness of lupus during
May," said Sandra Raymond,
President and CEO of the Lupus Foundation of
America. "Support from companies such as Questcor helps
us advance our mission to improve the quality of life for all
people affected by lupus."
About the Lupus Foundation of America:
The Lupus
Foundation of America is the only national force devoted to solving
the mystery of lupus, one of the world's cruelest, most
unpredictable and devastating diseases, while giving caring support
to those who suffer from its brutal impact. Through a comprehensive
program of research, education, and advocacy, the Foundation leads
the fight to improve the quality of life for all people affected by
lupus. Learn more about the Lupus Foundation of America at
www.lupus.org.
About Questcor Pharmaceuticals
Questcor
Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
treatment of patients with serious, difficult-to-treat autoimmune
and inflammatory disorders. Questcor's specific areas of focus are
in the fields of neurology, nephrology, pulmonology and
rheumatology, and the company is currently supporting research
efforts in a variety of conditions having significant unmet medical
need. For more information about Questcor, please visit
www.Questcor.com.
SOURCE Questcor Pharmaceuticals, Inc.